Summary & Overview
CPT 36460: Intrauterine Fetal Transfusion via Umbilical Vein
CPT code 36460 represents an intrauterine fetal transfusion performed by delivering blood through the fetal umbilical vein while the fetus remains in utero. This highly specialized, invasive procedure addresses fetal anemia and related perinatal hematologic emergencies and has implications for maternal-fetal medicine bundles, neonatal outcomes, and acute-care resource utilization across tertiary hospitals nationally. It is clinically significant due to its role in preventing fetal hydrops, stillbirth, and severe neonatal morbidity when timely performed.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of care, and the service type. The publication also outlines common billing and coding considerations, typical modifiers observed in practice (input provided), and national-level benchmark concepts where available. Where input data is incomplete, the text notes that specific items are not available.
This summary equips healthcare administrators, maternal-fetal medicine clinicians, and coding professionals with clear context for CPT code 36460, informing claims filing, payer discussions, and care pathway documentation without offering clinical recommendations.
Billing Code Overview
CPT code 36460 describes a procedure in which a provider performs a fetal transfusion via the umbilical vein while the fetus remains in utero. This service is an intrauterine fetal transfusion, typically performed to treat fetal anemia or alloimmunization-related conditions.
-
Service type: Invasive fetal therapeutic transfusion
-
Typical site of service: Hospital operating room or labor and delivery suite with maternal-fetal medicine and neonatal support
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves a pregnant patient in the second or third trimester presenting with fetal anemia diagnosed by middle cerebral artery Doppler surveillance, abnormal nonstress test, hydrops fetalis, or known alloimmunization (for example, maternal anti-D). After fetal anemia is confirmed by ultrasound assessment and laboratory correlation, maternal-fetal medicine specialists coordinate an intrauterine transfusion. In the operating/procedure suite or high-acuity obstetric unit, with continuous fetal monitoring and ultrasound guidance, the provider performs a percutaneous umbilical vein transfusion (intrauterine fetal transfusion) by placing a needle through the maternal abdomen and uterine wall into the fetal umbilical vein and transfusing packed red blood cells. The clinical workflow includes preprocedure maternal consent and Rh/antibody review, fetal ultrasound localization, hematologic preparation of matched irradiated, CMV-negative blood, intraprocedural ultrasound-guided venous access and transfusion, monitoring for fetal bradycardia or bleeding, and postprocedure observation with follow-up Doppler and possible repeat transfusion scheduling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician's professional component separate from technical resources (rare for this bundled procedure). |